Access Field Manager
About this opportunity
•在地方 （CPO） 级别领导实施可持续的患者访问战略。收集和分析数据，为患者访问提交内容生成见解，共同为客户、患者和诺华创造价值。
Major Accountabilities~ 领导项目向监管机构提交患者访问档案应用高标准的运营卓越性。 ~ 为本地产品开发决策提供早期相关意见。 ~ 为业务案例提供分析依据。 ~ 维护和更新所有相关的P&R工具和系统。 ~ 创建富有洞察力的报告，将诺华和竞争对手产品的定价和报销策略相关数据分析结果转化为有影响力的业务建议。 ~ 建立并利用与关键客户、关键意见领袖以及个人和机构关键决策者的强大网络和关系，优化诺华产品的定位和信息传递，并促进价值主张的共同创造。客户。 ~ 将本地输入引导到全局和本地定价。 ~ 调整全球医疗保健经济学模型以准确反映当地环境。Key Performance Indicators~诺华本地P&R和吸收目标的实现~有效使用和改进跟踪系统以衡量访问情况。~缩短产品上市时间~改善/扩大患者可及性Work Experience~有编制报销档案的经验~经证实，有能力理解并清楚地传达科学和经济主题~了解国家卫生保健、药品研发的监管环境和上市流程~强大的谈判和分析能力Skills~分析能力~计算机网络~金融~卫生经济学~卫生技术评估 （HTA）~大客户管理~植入式广告~价值主张~公共事务~市场准入~以客户为中心的思维方式~对医疗保健行业的理解~跨职能协作~真实世界证据 （RWE）~项目管理~流程管理~分析思维~敏捷Language英语
Job details
How this role compares
Computed from every other active Market Access role in our database, not just this employer's listings.
We currently track 83 comparable Manager Market Access roles across 20 biopharma companies.
Salary context
23 of 83 peers report a salary range (USD, annualized)
Peers share this role's job function and a matching or adjacent seniority level -- not necessarily the same therapeutic area or country.
Where these roles are based
Top locations among the 83 comparable roles
+ 12 more countries
Seniority mix
83 of 83 peers have a known seniority level
Therapeutic area mix
26 of 83 peers have a known therapeutic area; the rest are genuinely unlabeled, not hidden
Similar opportunities
The closest matches from our peer group, ranked by how similar they are, not how well you'd qualify for them -- treat this as market context, not a guaranteed shortlist; a weak match is labeled as one below.
How we calculate "similar"
No black box, no LLM guesswork: a deterministic score built from four normalized attributes. Here's this role's own peer group at different match levels, so you can see the mechanism, not just the result.
Every comparison starts from the same 100-point budget: 25 for working in the same function, 40 for the same therapeutic area, 20 for the same or adjacent seniority, 15 for the same country. A dimension we can't confirm on both sides contributes nothing, never a guess, never a free pass.
0 points, never a partial guess. A role we know almost nothing about beyond its function bottoms out at 25%; it never inflates to 100% just because there's little to compare against. Seniority uses a defined ladder (Associate → Manager → Associate Director → Senior → Principal → Director → Senior Director → Executive/VP) so "Director" and "Senior Director" count as adjacent, but "Director" and "Executive/VP" do not.